sertraline has been researched along with Multiple Sclerosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gil-Ad, I; Korob, I; Taler, M; Weizman, A | 1 |
| Chin, C; Cox, D; Epstein, L; Goldberg, A; Goodkin, D; Luks, TL; Mohr, DC; Nelson, S | 1 |
| Barrera, M; Classen, C; Mohr, DC | 1 |
| Fonareva, I; Hart, S; Merluzzi, N; Mohr, DC | 1 |
| Brill, P; McConnell, H; Nussbaum, P; Scott, TF | 1 |
| Arlinghaus, KA; Clearman, RR; George, MS; Kotrla, KJ; Nahas, Z | 1 |
| Bostrom, A; Boudewyn, AC; Epstein, L; Goodkin, DE; Mohr, DC | 1 |
5 trial(s) available for sertraline and Multiple Sclerosis
| Article | Year |
|---|---|
Brain lesion volume and neuropsychological function predict efficacy of treatment for depression in multiple sclerosis.
Topics: Adult; Antidepressive Agents; Brain; Cerebral Ventricles; Cognitive Behavioral Therapy; Depressive Disorder, Major; Dominance, Cerebral; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Neurologic Examination; Neuropsychological Tests; Outcome and Process Assessment, Health Care; Personality Inventory; Prognosis; Psychometrics; Psychotherapy, Group; Reproducibility of Results; Sertraline; Temporal Lobe | 2003 |
The relationship between social support, depression and treatment for depression in people with multiple sclerosis.
Topics: Adult; Antidepressive Agents; Cognitive Behavioral Therapy; Depression; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Psychiatric Status Rating Scales; Psychotherapy, Group; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Support; Treatment Outcome | 2004 |
Treatment for depression and its relationship to improvement in quality of life and psychological well-being in multiple sclerosis patients.
Topics: Adult; Antidepressive Agents; Behavior Therapy; Depressive Disorder; Female; Humans; Male; Multiple Sclerosis; Psychotherapy, Group; Quality of Life; Regression Analysis; Sertraline; Severity of Illness Index; Sickness Impact Profile | 2005 |
Measurement of treatment response to sertraline in depressed multiple sclerosis patients using the Carroll scale.
Topics: 1-Naphthylamine; Analysis of Variance; Antidepressive Agents; Depressive Disorder; Humans; Middle Aged; Multiple Sclerosis; Prospective Studies; Self-Assessment; Sertraline; Treatment Outcome | 1995 |
Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis.
Topics: Cognitive Behavioral Therapy; Depressive Disorder, Major; Female; Humans; Male; Multiple Sclerosis; Psychotherapy, Group; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires | 2001 |
2 other study(ies) available for sertraline and Multiple Sclerosis
| Article | Year |
|---|---|
The immunomodulatory effect of the antidepressant sertraline in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Topics: Animals; Antidepressive Agents; Cell Survival; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Immunologic Factors; Lymphocytes; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Selective Serotonin Reuptake Inhibitors; Sertraline | 2011 |
Rapid response of emotional incontinence to selective serotonin reuptake inhibitors.
Topics: Adult; Affective Symptoms; Aged; Brain Injuries; Cerebrovascular Disorders; Crying; Fluoxetine; Humans; Laughter; Male; Middle Aged; Multiple Sclerosis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |